GSK3B and esophageal squamous cell carcinoma: Prior studies have shown that in colorectal cancer and esophageal squamous cell carcinoma, YTHDF2 activates this pathway by targeting m6A-modified GSK3β and APC mRNAs for degradation [52, 53].